{
    "Trade/Device Name(s)": [
        "Acetaminophen L3K Assay"
    ],
    "Submitter Information": "Genzyme Diagnostics P.E.I. Inc.",
    "510(k) Number": "K081938",
    "Predicate Device Reference 510(k) Number(s)": [
        "K042330"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LDP"
    ],
    "Summary Letter Date": "May 1, 2009",
    "Summary Letter Received Date": "April 27, 2009",
    "Submission Date": "April 8, 2009",
    "Regulation Number(s)": [
        "21 CFR 862.3030"
    ],
    "Regulation Name(s)": [
        "Acetaminophen test system"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "toxicology"
    ],
    "Analyte(s)": [
        "Acetaminophen"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Colorimetry",
        "Aryl Acylamidase enzyme method",
        "Oxidative coupling"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Standard"
    ],
    "Document Summary": "FDA 510(k) summary for Genzyme Diagnostics Acetaminophen L3K Assay for quantitative measurement of acetaminophen in serum and plasma",
    "Indications for Use Summary": "For the quantitative measurement of acetaminophen in serum and plasma to aid in the diagnosis and treatment of acetaminophen overdose toxicity",
    "fda_folder": "Toxicology"
}